Thu.Mar 31, 2022

article thumbnail

Vertex gets positive trial results for non-opioid painkiller in boost to pipeline

Bio Pharma Dive

After several attempts at designing a drug for acute pain, Vertex has a candidate it's ready to take into late-stage testing following two successful Phase 2 studies.

Trials 332
article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

The House is preparing to vote on a $35 monthly insulin cap later, but there is stern opposition to the plan, which could cost billions over ten years. Essentially taxpayers would be subsidizing drug company profits for the price of a product that should have come down a long time ago. Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated pric

Insulin 240
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 FDA decisions to watch in the second quarter

Bio Pharma Dive

While a market downturn has weighed on the biotech industry, FDA approvals for drugs from Bristol Myers Squibb, Bluebird bio and Amylyx Pharmaceuticals could help the sector regain its footing.

article thumbnail

Benefits of Adopting Multichannel Marketing in Pharma

Pharma Mirror

It all started in March 2020 and it is now Jan 2022. We still can’t declare the COVID pandemic as “finished”. How has the pandemic impacted the field marketing activity of Pharma companies? What should the industry do to prepare for what will definitely be a new world, post-COVID? There were many analysts who, even before the pandemic, were saying that the role of Medical Representatives will reduce.

Marketing 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Positive results for Cerevance’s Parkinson’s drug

Pharma Times

In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication

Drugs 118
article thumbnail

Pipelinepharma marketplace records quadruple growth over a single year

Pharma Mirror

The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category.

More Trending

article thumbnail

Symbiosis announces successful completion of UK Research and Innovation (UKRI) project, which will enhance the manufacturing supply chain for ATMPs within the UK

Pharma Mirror

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge.

article thumbnail

Tyson Ventures, Whole Foods’ Accelerator Program and Other Food Companies Investing in Innovation

XTalks

Tyson Foods, a food and beverage giant with approximately 137,000 employees, is no stranger to thinking big. It built staple brands like Jimmy Dean, Hillshire Farms and of course, Tyson. But lately, big companies like Tyson are also thinking small. Tyson and Whole Foods are just two food giants that have developed formal programs to find and nurture small, entrepreneurial food and beverage companies.

article thumbnail

Coaching Consistency

pharmaphorum

Leading tennis players train two to three hours a day to prepare for tournaments and have daily coaching input to make them game ready. It’s a gruelling regime but the rewards are obvious. Competing at the top level in pharma sales could be developed by following in the fast footsteps of Roger Federer and Rafael Nadal. Experts believe time spent practising delivery and messaging will reap dividends providing it is grooved into a sales force or medical science liaison (MSL) team’s schedule.

Sales 98
article thumbnail

Innovative Purdue research leads to FDA-approved prostate cancer treatment

Outsourcing Pharma

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

New gene targets for treating adult blood cancer

Scienmag

Gene editing technology has been used to pinpoint new molecular targets for treating an aggressive form of leukemia in adults. Credit: Takashi Ishio, et al. Blood. November 24, 2021 Gene editing technology has been used to pinpoint new molecular targets for treating an aggressive form of leukemia in adults. Hokkaido University scientists have identified new […].

Gene 95
article thumbnail

ThermoGenesis launches automated cell therapy CDMO

BioPharma Reporter

The company will also begin work on creating a cGMP manufacturing facility in Sacramento, California, to house its CDMO division.

article thumbnail

New study solves mystery of how soft liquid droplets erode hard surfaces

Scienmag

A first-of-its-kind study led by University of Minnesota Twin Cities researchers reveals why liquid droplets have the ability to erode hard surfaces. The discovery could help engineers design better, more erosion-resistant materials. Credit: Cheng Research Group, University of Minnesota A first-of-its-kind study led by University of Minnesota Twin Cities researchers reveals why liquid droplets have […].

article thumbnail

Mission Therapeutics launches clinical trial for kidney disease therapy

Pharma Times

MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

UTEP names Robertson dean of College of Health Sciences

Scienmag

EL PASO, Texas (March 31, 2022) — The University of Texas at El Paso has named William H. Robertson, Ph.D., as the new dean of the College of Health Sciences. Robertson has served as interim dean of the college since March 2021. Previously, he served the University in other administrative roles including interim dean and […].

90
article thumbnail

Clinical Data Management with Mariam Mirgoli

Clinical Trial Podcast

There is more to the world of clinical data management than building and cleaning databases. Did you know you can leverage your clinical data for clinical operational excellence across your organization? To educate us on the nuts and bolts of clinical data management and how data can guide us with our clinical operations decision making, I invited Mariam Mirgoli, Vice President of Clinical Data Management at Iovance Biotherapeutics, Inc on the show.

article thumbnail

Warmer summers and meltwater lakes are threatening the fringes of the world’s largest ice sheet

Scienmag

A first-of-its-kind study looking at surface meltwater lakes around the East Antarctic Ice Sheet across a seven-year period has found that the area and volume of these lakes is highly variable year-to-year, and offers new insights into the potential impact of recent climatic change on the ‘Frozen Continent’. Credit: David Small, Durham University A first-of-its-kind […].

90
article thumbnail

Drug Channels News Roundup, March 2022: UM and Health Equity, Insurers ? White Bagging, Biosimilar Boom, A New Angle on Copay Support, and the Pharmacy Metaverse

Drug Channels

Ah, it’s finally spring in downtown Philadelphia, our home base. (Photographic evidence on your right.) Along with sunshine and fine weather, this vernal equinox has ushered in a crop of new and noteworthy stories: Health inequities in utilization management Insurers compute big white bagging savings The biosimilar boom accelerates The patient upside of manufacturers’ copay support Whoa.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Mid-level solar flare erupts from Sun

Scienmag

The Sun emitted a mid-level solar flare on March 31, 2022, peaking at 2:35 p.m. EST. NASA’s Solar Dynamics Observatory, which watches the Sun constantly, captured an image of the event. Credit: NASA/SDO The Sun emitted a mid-level solar flare on March 31, 2022, peaking at 2:35 p.m. EST. NASA’s Solar Dynamics Observatory, which watches […].

90
article thumbnail

Is customisation healthcare’s secret weapon? 

Drug Discovery World podcast

This is the latest episode of the free DDW podcast, “ Is customisation healthcare’s secret weapon? ”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. . The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”. . In the first article, “Optimising vaccine production through customisation”, John Yoshi Shyu, Ph.D.

article thumbnail

T. rex’s short arms may have lowered risk of bites during feeding frenzies

Scienmag

Over the two decades paleontologist Kevin Padian taught a freshman seminar called The Age of Dinosaurs, one question asked frequently by undergraduates stuck with him: Why are the arms of Tyrannosaurus rex so ridiculously short? He would usually list a range of paleontologists’ proposed hypotheses — for mating, for holding or stabbing prey, for tipping […].

86
article thumbnail

Bayer to strengthen global Pharmaceuticals production network

The Pharma Data

Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical division through enhanced focus on breakthrough innovation as well as through consolidation and modernization of its business operations.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Lost bioscapes window into Polynesian settlement circa 12th century

Scienmag

Polynesian explorers discovered a treasure trove of unique plants and animals when they arrived in the Marquesas Islands of French Polynesia, according to new research. Credit: University of Auckland Polynesian explorers discovered a treasure trove of unique plants and animals when they arrived in the Marquesas Islands of French Polynesia, according to new research.

article thumbnail

EUROAPI listing on Euronext Paris expected on May 6, 2022

The Pharma Data

French AMF approved EUROAPI’s listing prospectus EUROAPI first day of trading expected to occur on May 6, 2022 subject to the approval of the Distribution by the Ordinary and Extraordinary Shareholders’ Meeting to be held on May 3, 2022 Sanofi will host today a dedicated Capital Markets Day at 1:30 pm CET to present EUROAPI’s business in greater detail The Distribution ratio will be one (1) EUROAPI share per twenty three (23) Sanofi shares After the Distribution, Sanofi has confirmed its intenti

article thumbnail

Biomedical experts to headline Biophotonics Congress: Biomedical Optics Plenary Sessions

Scienmag

WASHINGTON – Engineers, optical and medical scientists, physicians, researchers, and graduate students will convene for this year’s Biophotonics Congress: Biomedical Optics in a hybrid format to be held 24 – 27 April, 2022 at the Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida. Credit: Optica WASHINGTON – Engineers, optical and medical scientists, physicians, researchers, […].

article thumbnail

New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)

The Pharma Data

Through Save Legs. Change Lives. ™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease. The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial fo

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New NV Energy Foundation grant will support wildfire preparedness in Nevada

Scienmag

Reno, Nev. (Mar. 31, 2022) – As the climate warms, wildfires in the Sierra Nevada are happening at unprecedented sizes and intensities, threatening communities and resources throughout Nevada and California. For fire managers trying to understand and predict fire behavior, access to accurate information for decision-making has never been more important.

82
article thumbnail

NIH begins clinical trial evaluating second COVID-19 booster shots in adults

The Pharma Data

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. The trial aims to understand if different vaccine regimens – prototype and variant vaccines alone and in combinations – can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

article thumbnail

Heart complications after a stroke increase the risk of future cardiovascular events

Scienmag

Embargoed until 4 a.m. CT/5 a.m. ET Thursday, March 31, 2022 DALLAS, March 31, 2022 — People who survive an ischemic stroke are much more likely to develop major heart complications during the first month after their stroke, and, as a result, they also have an increased risk of death, heart attack or another stroke within five years, compared […].

article thumbnail

Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicines

The Pharma Data

Sanofi successfully priced yesterday, March 30, 2022, its offering of a dual-tranche EUR 1.5 billion of notes (the “Notes”). It comprises an inaugural issue of sustainability-linked bond for a nominal amount of EUR 650 million of notes, tied to Sanofi’s commitment to improve access to essential medicines in low- and lower-middle-income countries via its global health nonprofit unit.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.